Strata Critical Medical IncSRTA
Price$4.83

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $256M+74.3% YoYTTM through 30 Jun 2026
Net Income $40.2MTTM through 30 Jun 2026
Free Cash Flow -$48.4MTTM through 30 Jun 2026

Margins

Current
Gross Margin21.0%
EBITDA Margin-1.6%
Operating Margin-4.4%
Net Margin15.7%

Returns

0.8%ROE
0.7%ROA

Balance Sheet Health

Debt / Equity0.02x
Current Ratio3.13x
Net Debt-$54.3Mnet cash position
Cash & Equivalents$16.3M

Quality Metrics

Altman Z-Score5.64
Piotroski F-Score4 / 9
FCF Margin-18.9%
Rule of 40-11.8
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $197.1M
Diluted EPS$0.49TTM
'19'20'21'22'23'24'25
FY2025: $0.50

Dividend

No dividend

Capital Allocation

Capex Intensity4.9%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.